| __timestamp | Soleno Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 22223073 |
| Thursday, January 1, 2015 | 4536244 | 6966842 |
| Friday, January 1, 2016 | 5184803 | 9000499 |
| Sunday, January 1, 2017 | 3068742 | 13741186 |
| Monday, January 1, 2018 | 7178000 | 19040000 |
| Tuesday, January 1, 2019 | 16267000 | 23559000 |
| Wednesday, January 1, 2020 | 23191000 | 31931000 |
| Friday, January 1, 2021 | 21453000 | 44981000 |
| Saturday, January 1, 2022 | 15265000 | 54234000 |
| Sunday, January 1, 2023 | 25189000 | 63806000 |
Cracking the code
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Viking Therapeutics, Inc. and Soleno Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Viking Therapeutics has consistently outpaced Soleno Therapeutics, with its R&D expenses growing by nearly 187%, reaching a peak in 2023. This surge underscores Viking's aggressive pursuit of new therapies and market leadership. In contrast, Soleno's R&D spending, while showing a steady increase, has grown by approximately 102% over the same period.
The data reveals a fascinating narrative of strategic priorities and market positioning. As Viking Therapeutics continues to invest heavily in innovation, Soleno Therapeutics maintains a more measured approach, reflecting different strategies in the competitive biotech landscape.
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
United Therapeutics Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Soleno Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Apellis Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Protagonist Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Dynavax Technologies Corporation
Comparing Innovation Spending: Viking Therapeutics, Inc. and Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Soleno Therapeutics, Inc. and Evotec SE